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A B S T R A C T
Lung cancer is a major public health problem due to its high incidence and mortality rate. The altered meta-
bolism in lung cancer is key for the diagnosis and has implications on both, the prognosis and the response to
treatments. Although Cancer-associated ﬁbroblasts (CAFs) are one of the major components of the tumor mi-
croenvironment, little is known about their role in lung cancer metabolism.
We studied tumor biopsies from a cohort of 12 stage IIIA lung adenocarcinoma patients and saw a positive
correlation between the grade of ﬁbrosis and the glycolysis phenotype (Low PGC-1α and High GAPDH/MT-CO1
ratio mRNA levels). These results were conﬁrmed and extended to other metabolism-related genes through the in
silico data analysis from 73 stage IIIA lung adenocarcinoma patients available in TCGA. Interestingly, these
relationships are not observed with the CAFs marker α-SMA in both cohorts.
To characterize the mechanism, in vitro co-culture studies were carried out using two NSCLC cell lines (A549
and H1299 cells) and two diﬀerent ﬁbroblast cell lines. Our results conﬁrm that a metabolic reprogramming
involving ROS and TGF-β signaling occurs in lung cancer cells and ﬁbroblasts independently of α-SMA induc-
tion. Under co-culture conditions, Cancer-Associated ﬁbroblasts increase their glycolytic ability. On the other
hand, tumor cells increase their mitochondrial function. Moreover, the diﬀerential capability among tumor cells
to induce this metabolic shift and also the role of the basal ﬁbroblasts Oxphos Phosphorylation (OXPHOS)
function modifying this phenomenon could have implications on both, the diagnosis and prognosis of patients.
Further knowledge in the mechanism involved may allow the development of new therapies.
1. Introduction
One of the tumor cell´s hallmarks is its altered metabolism, adapted
to support a rapid cell growth [1]. This, from a basic standpoint, is
achieved by an increase in aerobic glycolysis, known as the Warburg
eﬀect, which allows the contribution of intermediary metabolites used
in anabolic processes [2,3]. In fact, one of the most important systems
for cancer diagnosis, positron emission tomography with the radio-
pharmaceutical 18-Fluorodeoxyglucose (FDG-PET), is based on this
singular metabolism of tumors, which forces them to consume more
glucose than the surrounding tissues [4].
Despite the importance of this altered metabolism, there is a lack of
molecular and functional studies that approximate to what is really
happening in vivo. We know now that tumors are not uniform masses of
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cells. Besides the transformed cells, many cell types coexist, including
ﬁbroblasts, endothelial or immune cells, which results in what is known
as tumor microenvironment. Following this line of thought, over the
last years many studies focusing on the microenvironment have been
conducted. This interest relies on the fact that diﬀerent cell types
communicate with each other, changing their behavior and thus con-
ditioning tumor metabolism [5], tumor progression [6], and treatment
response [7]. Therefore, additional studies on cancer metabolism are
needed taking into account this complexity, since most studies have
focused exclusively on analysis of isolated tumor cell lines. It is likely
that the discrepancy between cancer basic knowledge and its clinical
application is due to underestimation of the microenvironment com-
ponent of tumors.
One of the most important components of the tumor micro-
environment are the cancer associated ﬁbroblasts (CAFs) [8], identiﬁed
by the expression of proteins such as α-smooth muscle actin (α-SMA)
and ﬁbroblast activation protein (FAP) [9]. The role of CAFs at meta-
bolic level has been recently described as the Reverse Warburg eﬀect.
According to this model, tumor cells within the microenvironment
would activate the ﬁbroblasts present by diﬀerent factors and would
control them, taking advantage of their metabolism. Although this
phenomenon is still not completely understood, it seems to implicate a
decrease on mitochondrial function in CAFs with the ensuing increase
on glycolysis. This metabolic shift would lead to a release of highly
energetic metabolic substrates to the microenvironment that would be
used by the tumor cells through an increased OXPHOS function
[10–13].
We have focused on lung cancer because it is a major public health
problem. Lung cancer is the most common cancer worldwide in terms of
incidence and it is also the leading cause of cancer-related death in the
world despite new targeted therapies based on their mutational proﬁle
have been incorporated [14–16]. Approximately one-third of patients
with non-small cell lung cancer (NSCLC) are diagnosed with locally
advanced (stage III) disease. These patients experience poor overall
survival due to the presence of metastatic diseases that are not ade-
quately detected. Therefore, many patients are subjected to aggressive
localized treatments, such as surgery or radiotherapy, when they al-
ready present advanced distant disease [17].
Usually lung tumors have a variable component of mesenchymal-
parenchyma composed mainly of ﬁbroblasts and collagen ﬁbers [18].
Importantly, in spite of the clinical relevance of lung cancer (in which
FDG-PET is a key diagnostic tool [19] and the ﬁbroblasts are an im-
portant component of tumors [20]) the role of the microenvironment in
metabolic reprogramming has not been studied.
Our results on stage IIIA NSCLC patients show a positive correlation
between the grade of ﬁbrosis and the glycolysis phenotype of the tumor.
In vitro studies conﬁrm that, a metabolic reprogramming involving ROS
and TGF-β signaling occurs in lung cancer cells and ﬁbroblasts in-
dependently of α-SMA induction and suggest that speciﬁc attributes
among tumor cells and ﬁbroblasts may modify or hamper this phe-
nomenon.
2. Materials and methods
2.1. Patients
A cohort of 12 stage IIIA adenocarcinoma patients was studied. All
studies were carried out using the Formalin-Fixed Paraﬃn Embedded
tissue (FFPET) from diagnostic biopsies. All the experiments carried out
in this study complied with current Spanish and European Union laws
and the principles outlined in the Declaration of Helsinki. The study and
experimental protocols were approved by the Hospital Universitario
Puerta de Hierro Ethics Committee and written informed consent was
obtained from all the patients recruited.
2.2. Fibrosis grade
The ﬁbrosis grade was evaluated in the hematoxylin-eosin diag-
nostic slides at x50 magniﬁcation. A low (<1/3 desmoplastic stroma)
or high (> 1/3 desmoplastic stroma) score was assigned to each sample
by three independent anatomical pathology technicians. Vimentin and
cytokeratin immunostaining of tumor biopsies using speciﬁc antibodies
were carried out to conﬁrm the correct identiﬁcation of tumor cells and
ﬁbroblasts on the hematoxylin-eosin samples.
2.3. RT-qPCR expression analysis
The RNA extraction from FFPET biopsies was performed using the
“High Pure FFPET RNA isolation Kit” (Roche). The RNA from cells was
extracted using the “RNeasy mini Kit with DNAse” (Qiagen) and the
cDNA was synthetized using the “NZY First-Strand cDNA Synthesis Kit”
(NZYtech).
PGC-1α, GAPDH, MT-CO1, LDHA, α-SMA, MCT4 and TGF-β mRNA
expression was measured by qRT- PCR using the Taqman® gene ex-
pression assays Hs01016719_m1, Hs02758991_g1, Hs02596864_g1,
Hs01378790_g1, Hs00426835_g1, Hs00358829_m1 and
Hs00998133_m1 respectively. TBP (Hs00427621_m1) was used as en-
dogenous control [21].
2.4. In silico analysis of TCGA patients
73 stage IIIA lung adenocarcinoma patients were analyzed using R2:
Genomics Analysis and Visualization Platform (http://r2.amc.nl, da-
taset id “Tumor lung adenocarcinoma – TCGA – 515 –rsem-tcgars“).
2.5. Cell lines
A549 and H1299 were obtained from the ATCC, Control Fibroblasts
1, 2 and 3 (CF1, CF2, CF3) were primary cultures derived from healthy
donors and the Aﬀected Fibroblast (AF) is the commonly used BJ h-tert
immortalized ﬁbroblast. The word "aﬀected" indicates that this ﬁbro-
blast has a reduced OXPHOS function of unknown origin, as described
in results section.
The H1229 cell line was transfected with the plasmid pKatushka2S
(K2S from now) [22] using lipofectamine 2000 reagents (Thermo Fisher
Scientiﬁc) following manufacturer instructions. The eﬃciency was
evaluated by ﬂow cytometry and 48 h after transfection the cells were
selected for one month in DMEM containing G418 0,5 mg/mL. Several
clones were isolated by limit dilution and evaluated for their growing
capabilities in glucose/galactose, ﬂuorescence intensity, and transfec-
tion stability (data not shown). The K2S positive clone, with more si-
milar properties to the parental H1299 cell line, named H1299 K2S, was
used to carry out all the following experiments.
All cells were cultured routinely in DMEM, with 10% Fetal Bovine
Serum (FBS) and Penicillin Streptomycin (Gibco).
2.6. Galactose and glucose growth rates
Cell growth was assayed as described previously [23]. Brieﬂy, cell
growth was assayed after growing the cells for 4 days in DMEM con-
taining either 4.5 g/L glucose or 0.9 g/L galactose as carbon source. The
cells were harvested and counted every 24 h and the growth rates were
calculated using Doubling Time Software v3.1.0 (http://www.doubling-
time.com). Mean was calculated from at least three diﬀerent experi-
ments.
2.7. Co-culture experiments
Cells were co-cultivated, without refreshing the media, for 4 days.
Cells reached approximately a 90% conﬂuence and were analyzed by
ﬂow cytometry or confocal microscopy.
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The experiments involving ﬁbroblast cells were seeded at 1:3 ratio
(tumor cell line: ﬁbroblast). The day of the analysis, cell lines propor-
tions were near 1:1 due to their diverse growth rates. For the eﬀect
between diﬀerent tumor cell lines (A549 and H1299), cells were seeded
accordingly to their growth rate to reach approximately a ﬁnal ratio of
1:1.
To study the involvement of the basal ﬁbroblast OXPHOS function
in this process, ﬁbroblasts were treated with 50 µg/mL of EtBr prior the
experiments. After four days of drug exposure, the EtBr was removed
and the ﬁbroblasts were co-cultivated and analyzed as described above.
2.8. Flow cytometry
The mitochondrial inner membrane potential (MIMP) and
Cytoplasmic ROS were assessed using tetramethyl rhodamine ester
(TMRE, Invitrogen) and 2′,7′-dichlorodihydroﬂuorescein diacetate
(H2DCF-DA, Invitrogen) respectively.
After addition of the ﬂuorophores (30 µM H2DCF-DA, 100 nM
TMRE) and incubation at 37 °C for 30min in the dark, cells were col-
lected in DMEM and analyzed immediately with a MACSQuant®
(Miltenyi-Biotec) ﬂow cytometer. Forward and side scatter were used to
gate the viable population of cells and the mean ﬂuorescence intensity
was determined with FLOWJO (TreeStar). K2S or EpCAM (CD326,
Miltenyi-Biotec) positivity in the 655–730 nm bandpass channel was
used to distinguish between tumor and ﬁbroblast cells in co-culture.
For cell sorting, 4× 106 co-cultured cells were analyzed and sorted
using a FASCAria II sorter in two populations (K2S positive and K2S
negative) corresponding to H1299 cells or ﬁbroblasts respectively.
Monocultured cells mixed just before sorting were used as control. Cells
were centrifuged after cell sorting and the pellets were immediately
frozen until RNA extraction.
For the eﬀect of TGF-β on MIMP and ROS levels, 0.75×106 cells
were grown on MW6 plates and TGF-β was added to a ﬁnal con-
centration of 10 ng/µL and refreshed every day. After 4 days, cells were
harvested and MIMP and ROS were evaluated as described previously.
2.9. Immunoﬂuorescence analysis
After 4 days of co-culture, immunoﬂuorescences using speciﬁc an-
tibodies for MCT4 (sc-50329, Santa Cruz Biotechnology), TOM20 (sc-
17764, Santa Cruz Biotechnology) and α-SMA (1 A4; Abcam) were
carried out as described previously [24].
2.10. Statistics
Results were analyzed using a 2-tailed Student's t-test to assess
statistical signiﬁcance. Diﬀerences in PGC-1α and GAPDH/MT-CO1
ratio levels between Low and High ﬁbrosis groups were evaluated using
ANOVA. Bivariate correlations studies between gene expressions were
analyzed using the Pearson correlation test. Values of P < 0.05 were
considered statistically signiﬁcant.
3. Results and discussion
3.1. The ﬁbroblast component increases the glycolytic phenotype of tumors
As a ﬁrst approach to study the role of the ﬁbroblast component of
tumors, we studied the correlation of PGC-1α (master regulator of
mitochondrial metabolism) and the GAPDH/MT-CO1 ratio mRNA le-
vels with the ﬁbrosis grade in a cohort of 12 stage IIIA lung adeno-
carcinoma patients (Fig. 1A). The results showed signiﬁcant diﬀerences
in PGC-1α (p=0.048) and GAPDH/MT-CO1 levels (p=0.006) between
high and low ﬁbrosis grade in the tumor biopsies. Interestingly, an
increase in ﬁbroblast component present in the tumor leads to higher
levels of the ratio GAPDH/MT-CO1 and lower levels of PGC-1α, which
are typical of an increased glycolytic metabolism and increased PET
uptake [25].
To conﬁrm these results, expression data from 73 patients with
stage IIIA pulmonary adenocarcinoma present in the TCGA database
were analyzed using the bioinformatic tool “R2: Genomics Analysis and
Visualization Platform”. The correlations between vimentin levels (as
marker of the ﬁbroblast component) with the levels of genes related to
glucose metabolism (Glycolysis, TCA and OXPHOS system) were ana-
lyzed. The results show a similar change to that described in our cohort
of patients (Fig. 1B and Supplementary Table 1). Overall, the results
show a positive correlation of vimentin levels with genes related to an
increase in glycolytic metabolism (GLUT3, HIF1A, HK3, ENO,
PFKFB4…). On the other hand, genes related to the Krebs cycle (FH,
MPC2, IDH3A, CS, SUCLG1…) or related to OXPHOS complexes
(ATP5G3, NUDFA8,9,10, SDHA,C, COX5A…) and their assembly fac-
tors (COA5, COA6, NDUFAF5, UQCC2…) negatively correlate with vi-
mentin levels in the tumor. Interestingly, some of these genes have been
described in CAFs reprograming. The downregulation of IDH3A (Iso-
citrate dehydrogenase 3α) has been pointed out as responsible for the
metabolic switch in CAFs trough HIF1α stabilization [26]. Remarkably,
the only OXPHOS subunits that correlate positively with the vimentin
levels are NDUFA4L2, COX7A1 y COX7B2, being the ﬁrst two subunits
related to hypoxia [27–29] and the third of unknown function.
It seems clear that an increase in ﬁbroblast component in the tumor
produces an increase in glycolytic genes with a decrease in OXPHOS
genes. However, in literature, the glucose metabolism of diﬀerentiated
cells such as normal ﬁbroblasts is more oxidative than the metabolism
of proliferative tumor cells [2].
Our results evaluating the metabolism of monocultured tumor cells
(A549 and H1299) and normal ﬁbroblasts conﬁrm this. The mi-
tochondrial inner membrane potential (MIMP) and the galactose to
glucose growth ratio were higher for the ﬁbroblast cell lines compared
to the tumor cell lines A549 and H1299 (Fig. 1C).
Thus, despite the behavior of the cells in monoculture, the results on
the tumor biopsies showed another role for the ﬁbroblasts. Both results
would indicate a possible eﬀect of metabolic reprogramming towards
glycolytic metabolism in the CAFs of NSCLC, that would modify the PET
images [30]. However, we cannot rule out whether this relationship is
produced by a speciﬁc metabolic change of tumor cells that would be
more glycolytic in response to the ﬁbroblasts present in the micro-
environment, if it is the presence of metabolically reprogramed ﬁbro-
blasts in the sample with a more glycolytic metabolism, or even a
combination of both theories.
3.2. The in vitro co-culture of ﬁbroblasts and NSCLC cells induce a
metabolic reprogramming in both cell types
To clarify these issues and to deepen the mechanisms of this me-
tabolic relationship in NSCLC we decided to move on to an in vitro
model of co-cultured tumor and ﬁbroblasts cell lines (Fig. 2A).
To identify the A549 cells in the co-culture analysis, we exploited
their positivity for the epithelial membrane marker EpCAM, which ef-
ﬁciently discriminates these cells from the accompanying ﬁbroblasts
through antibody labeling. On the contrary, since the H1299 line has
lost many of the epithelial markers it is not possible to distinguish it
from the co-cultured ﬁbroblasts. Thus, we transfected the H1299 cell
line to stably express the far-red ﬂuorescent protein Katushka2S [22].
This strategy allowed us to identify the diﬀerent cell lines when co-
cultured with ﬁbroblasts and measure other parameters, both by ﬂow
cytometry and confocal microscopy (Fig. 2A).
After 4 days of co-culture with CF1 (Control Fibroblast 1), the MIMP
was measured. MIMP is one of the most representative parameters
modiﬁed in the metabolic reprogramming of co-cultured cells [10].
Surprisingly, we only saw changes in MIMP for the H1299 cell line, but
no changes were observed for A549 cells when co-cultured (Fig. 2B).
Furthermore, when CF1 was co-cultured with the H1299 cell line a
decrease in the MIMP was observed, eﬀect that does not occur when
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Fig. 1. The ﬁbroblast component increases the glycolytic phenotype of tumors. (A) Upper panels, representative images for High and Low desmoplastic stroma
in NSCLC samples. Lower panels, PGC-1α and GAPDH/COX1 mRNA levels correlate with ﬁbrosis grade. (B) Representative graphs showing the correlation of
vimentin expression with diﬀerent glucose metabolism genes. (C) Monocultured normal ﬁbroblasts (CF1, CF2, CF3) have higher OXPHOS function than tumor cell
lines.
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CF1 is co-cultured with the A549 cell line.
To test if this metabolic reprogramming on H1299 cells was ﬁbro-
blast-speciﬁc, or if it was just produced by diﬀerent cells that cohabit in
the same space, we co-cultured the H1299 K2S cell line with A549 cells
(Fig. 2C). The results showed no signiﬁcant diﬀerences in both cell lines
when co-cultured together, reinforcing the speciﬁc role of the
(caption on next page)
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ﬁbroblasts in this process.
We measured the LDHA and PGC-1α mRNA levels after the co-
culture in both, H1299 and ﬁbroblast cells (Fig. 2D). The results showed
an increase of LDHA expression in the co-cultured ﬁbroblasts and an
increase of PGC-1α in the co-cultured tumor cells supporting a meta-
bolic shift towards glycolysis in the ﬁbroblasts and a metabolic shift
towards OXPHOS in the tumor cells.
The OXPHOS function modiﬁcation has been associated with an
increase in mitochondrial mass in co-cultured tumor cells and a de-
crease of it in the ﬁbroblasts [10,12]. Beyond the levels of PGC-1α, we
used the amount of TOM20 protein to directly asses the mitochondrial
mass by confocal microscopy independently of the MIMP. The quanti-
ﬁcation of this protein revealed a signiﬁcant increase of the mi-
tochondrial mass when the tumor cells are co-cultured with control
ﬁbroblasts, however no statistically signiﬁcant diﬀerences were seen on
co-cultured control ﬁbroblasts (Fig. 2E). This point out diﬀerent me-
chanisms for the MIMP changes in each cell type. Thus, the MIMP rise
in tumor cells may be associated to PGC-1α and mitochondrial mass
increase. However, the decrease of MIMP in ﬁbroblast occurs without
any signiﬁcant modiﬁcation in PGC-1α or mitochondrial mass levels.
These results support the existence of a metabolic reprogramming in
NSCLC cells and ﬁbroblasts in vitro, although this is restricted to some
cell lines. Furthermore, these results may indicate that this change to-
wards a more glycolytic metabolism in the whole tumor in patients with
increased amount of ﬁbroblasts is caused by the increased glycolytic
metabolism of CAFs. This would also reinforce why ﬁbroblasts parti-
cipate in a worse prognosis of the patient [31], since they not only favor
immunosuppression [32], metastasis [33] or drug resistance [7], but
also would generate a tumor mass with a greater glucose uptake, which
is usually associated with tumor's aggressiveness [34,35].
The fact that one tumor cell line induces this phenomenon and the
other one does not on the same ﬁbroblast cell line speaks of some de-
termining characteristic of this process present in the tumor cell line. If
these diﬀerences were also to be found in patients, it would be possible
to identify diﬀerent groups of patients based on their ability to induce
this eﬀect on the microenvironment, which would have implications for
the diagnosis, staging or new drugs development.
3.3. Fibroblast metabolic reprogramming is not dependent on α-SMA
expression
In literature, the metabolic coupling between ﬁbroblasts and tumor
cells is associated with the ﬁbroblast activation process measured as α-
SMA expression [36]. The role of α-SMA levels in NSCLC is con-
troversial, with studies indicating that it is an unfavorable prognostic
factor [37] and studies in which α-SMA did not showed any prognostic
information [38].
We characterized the ability to activate ﬁbroblasts from the two
NSCLC cell lines used in the co-culture experiments (A549 and H1299).
Our results show that the A549 cell line and the H1299 cell line present
diﬀerent ability to activate ﬁbroblasts when co-cultured, measured as
the induction of α-SMA expression in the ﬁbroblasts (Fig. 3A). After 4
days of co-culture, A549 cells induce an increase in α-SMA expression
(at both, mRNA and protein levels) in the two diﬀerent ﬁbroblast cell
lines. On the other hand, H1299 cells are only capable of activate the
CF1, and to a much lesser extent than A549 cells.
This diﬀerential ability of the tumor cells correlates with the ex-
pression of epithelial markers, such as EpCAM (Fig. 3B) and E-Cadherin
(data not shown), as described before [39]. The H1299 cells with more
mesenchymal characteristics were less eﬀective at activating α-SMA
expression than A549 cells with more epithelial characteristics.
Interestingly, since A549 is the cell line that induces more α-SMA in
the ﬁbroblasts but it is not able to reproduce the metabolic change,
these results question the assumption in which the reverse Warburg
eﬀect is associated with the ﬁbroblast activation, suggesting that these
phenomena are two diﬀerent entities that do not necessarily occur to-
gether.
On the other hand, these in vitro results suggest that α-SMA level
may not be a good marker for the metabolic reprogramming eﬀect in-
duced by ﬁbroblasts in NSCLC tumors. To test this hypothesis, we re-
analyzed the patient's data from our cohort (data not shown) and from
TCGA. The results show no correlation between α-SMA expression and
PGC-1α or GAPDH/MT-CO1 (Fig. 3C).
3.4. Fibroblast basal OXPHOS function modiﬁes tumor cells metabolic
reprogramming
It seems clear that there is a metabolic change in both cell types,
whereas the H1299 tumor cells increase its OXPHOS function, the ﬁ-
broblasts reduce it when co-cultured. We asked ourselves if this process
occurred in a similar way if we co-cultivated the tumor cell line H1299
with a ﬁbroblast with an aﬀected OXPHOS function.
Coincidentally, when we characterized the mitochondrial function
of the ﬁbroblasts present in the laboratory, we observed deep diﬀer-
ences in their galactose to glucose growth rate ratios as well as in their
MIMP for one ﬁbroblast cell line (Aﬀected Fibroblast, AF) (Fig. 4A).
This result would indicate that these ﬁbroblasts present an OXPHOS
defect of unknown origin. Interestingly, this OXPHOS defect is
somehow compensated by an increased glycolytic function as evi-
denced by their increased LDHA mRNA levels. Moreover, in order to
have an isogenic model with a decreased OXPHOS function, we treated
the CF1 with EtBr (ethidium bromide) [40]. The treatment with EtBr
greatly reduced the MIMP, and speciﬁcally stopped the growth of cells
in galactose, without aﬀecting their growth in glucose (Fig. 4A).
We studied the levels of MCT4 (responsible for the lactate export
from the cytoplasm to the microenvironment) for both, monoculture
and co-culture conditions (Fig. 4B). The basal MCT4 levels of CF1 were
not detectable by immunoﬂuorescence. On the contrary, the CF1
treated with EtBr or the Aﬀected Fibroblast showed a notable MCT4
expression reinforcing their higher glycolytic activity. Remarkably,
after the co-culture with tumor cells, an increase of MCT4 levels was
induced on CF1, similarly to the LDHA increase observed (Fig. 2B) and
therefore supporting a glycolytic shift in the ﬁbroblasts. On the other
hand, the CF1 treated with EtBr or the AF maintain their already high
MCT4 levels that did not signiﬁcantly change. Similar results were
obtained analyzing MCT4 mRNA levels. CF1 showed lower MCT4
mRNA levels than the AF. Furthermore, MCT4 mRNA levels were in-
duced in CF1 after tumor co-culture but no diﬀerences were observed
after tumor co-culture in Aﬀected Fibroblast MCT4 mRNA levels.
Additionally, after 4 days of co-culture with the diﬀerent ﬁbroblasts,
the results showed a greater MIMP increase for the H1299 cell line
when it is co-cultivated with ﬁbroblasts with a diminished OXPHOS
Fig. 2. The Eﬀect of ﬁbroblast co-culture in NSCLC cell lines. (A) Representative image of the co-cultures. Upper panel, confocal image of H1299 cells co-cultured
with control ﬁbroblasts (CF1). TMRE in red, H1299 K2S positive cells in blue. Lower panel, representative ﬂow cytometry analysis of the co-cultures. Fibroblast and
tumor cells were not distinguishable by size and complexity (forward and side scatter). K2S (for H1299 cells) or EpCAM (for A549 cells) positivity was used to gate
and discriminate the tumor cells from the ﬁbroblasts (B) MIMP was evaluated as TMRE ﬂuorescence determined by ﬂow cytometry. Data are means relative to
monocultured tumor cells. Note that there are signiﬁcant diﬀerences in co-cultured cells for the H1299 but not for A549 cell line. (C) No signiﬁcant diﬀerences in
MIMP were seen in the co-culture between tumor cell lines. (D) The eﬀect of ﬁbroblast co-culture on LDHA and PGC-1α mRNA levels determinated by RT-qPCR (E)
Mitochondrial mass was determinated by confocal quantiﬁcation of TOM20 expression. Data are means from at least three diﬀerent experiments and are represented
relative to monocultured cells. Error bars indicate standard deviation. Student's t-test p-value was considered to be statistically signiﬁcant when was< 0.05
(*=p≤ 0.05).
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Fig. 3. Metabolic reprogramming is not dependent on α-SMA expression. (A) Left panel, α-SMA confocal images of two diﬀerent ﬁbroblasts cell lines co-cultured
with A549 or H1299 tumor cells. Right panel, ﬁbroblast α-SMA mRNA levels induced by tumor cell co-culture. Data are means from at least three diﬀerent
experiments. Error bars indicate standard deviation. Student's t-test p-value was considered to be statistically signiﬁcant when was< 0.05 (*=p≤ 0.05). Cells in
monoculture were used as controls. Note that the co-culture with A549 cells induce a higher α-SMA expression than H1299 co-culture (B) Epithelial marker EpCAM
by ﬂow cytometry. A549 cells are positive for EpCAM and E-Cadherin (data not shown) markers, on the other hand ﬁbroblasts and H1299 cells are negative. (C) α-
SMA expression do not correlate with PGC-1α or GAPDH/COX5A in patients.
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function (Fig. 4C). On the other hand, the AF and the CF1 treated with
EtBr do not behave the same way as the CF1 when co-cultured with
H1299. Whereas the CF1 decrease its MIMP the AF or the CF1 treated
with EtBr did not show any statistical diﬀerences (Fig. 4C). It is possible
that the latter cell lines are not able to diminish their OXPHOS function
more than it is already reduced, which would also explain why they do
not increase their expression of MCT4.
Moreover, we measured PGC-1α mRNA levels as indirect
Fig. 4. The role of Fibroblast OXPHOS function in metabolic re-
programming of co-cultured cells. (A) OXPHOS function character-
ization of ﬁbroblast cell lines. (CF1; Control Fibroblast 1, CF1+EtBr;
Control Fibroblast 1+ Ethidium Bromide, AF; Aﬀected Fibroblast).
Note the profound diﬀerences both in their galactose to glucose growth
rate ratios as well as in their MIMP and LDHA mRNA levels. (B) Left
panel, immunoﬂuorescence confocal images of MCT4 induction in ﬁ-
broblasts after 4-day co-culture with H1299 cells. (MCT4 antibody in
green and TO-PRO-3 staining the nucleus in blue). Right panel, MCT4
mRNA levels induced by co-culture with H1299 cells (C) MIMP changes
produced by co-culture with diﬀerent ﬁbroblast. (D) PGC-1α mRNA
levels on H1299 cell line when co-cultured with control and Aﬀected
Fibroblasts and on both ﬁbroblasts co-cultured with H1299 cell line.
Data are means from at least three diﬀerent experiments. Error bars
indicate standard deviation. Student's t-test p-value was considered to
be statistically signiﬁcant when was< 0.05 (*=p≤ 0.05).
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measurement of the mitochondrial biogenesis, which, as we had seen
previously, was altered by the co-culture with CF1. Our results show a
greater increase of the mitochondrial biogenesis when the H1299 line is
co-cultivated with the AF. In turn, the decrease of PGC-1α expression is
higher for these ﬁbroblasts than for the CF1 when co-cultured with
H1299 (Fig. 4D). These results would indicate that this process occurs
even on an OXPHOS-aﬀected ﬁbroblast. In fact, this seems to facilitate
the MIMP and PGC-1α increase of the tumor cells.
Fig. 5. Reactive Oxygen Species and TGF-β in meta-
bolic reprogramming. ROS levels were evaluated using
the H2DCFH-DA ﬂuorescent probe by ﬂow cytometry. (A)
Basal ROS levels in monocultured A549 and H1299 cells.
Note the fourfold increase in ROS levels for the H1299
cells (B) ROS levels on A549 cells and control ﬁbroblasts,
ROS levels are not modiﬁed after co-culture. (C) H1299
cells increase their ROS levels after co-culture with two
diﬀerent ﬁbroblasts cell lines. (D) TGF-β mRNA levels
measured by RT-qPCR in the cells were increased in all
the cell lines studied. Note that the co-culture with af-
fected ﬁbroblasts augments the eﬀect on H1299 cells
compared to control ﬁbroblasts. (E) Eﬀect on MIMP and
ROS levels of TGF-β addition to monocultured cells. Data
are means relative to monocultured tumor cells from at
least three diﬀerent experiments. Error bars indicate
standard deviation. Student's t-test p-value was considered
to be statistically signiﬁcant when was< 0.05
(*=p≤ 0.05).
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Fibroblasts with an aﬀected OXPHOS function seems to facilitate the
reverse Warburg eﬀect probably through their higher supply of lactate
due to their impaired OXPHOS function [41]. Recently, lactate has been
proposed as a potential carbon source for lung tumors in vivo [42] and
metabolic diﬀerences between CAFs from high and low glycolytic tu-
mors have been found [34].
All this data combined with the variability of mitochondrial func-
tion among healthy individuals (a common drawback in the study of
mitochondrial diseases [43]) would place the OXPHOS performance of
ﬁbroblasts as a modiﬁer element of tumor metabolism.
In relation to the previous sections, these results conﬁrm that the
H1299 cell line presents the ability to modify the metabolic micro-
environment in which is present, since it occurs in the presence of two
ﬁbroblasts from diﬀerent origins. Furthermore, since the AF do not
become signiﬁcantly activated in the presence of the H1299 cell line
(Fig. 3A), but nevertheless they produce a greater eﬀect on the MIMP of
the tumor line, this result conﬁrms that this process of metabolic re-
programming is independent of ﬁbroblast activation measured as α-
SMA induction.
3.5. Reactive oxygen species levels in co-cultured NSCLC cells
One of the main factors responsible for metabolism reprogramming
is ROS [10]. We measured the basal ROS, in both tumor cell lines, using
the ﬂuorescent probe H2DCFH-DA. The results showed a signiﬁcant
fourfold increase of ROS for H1299 cells compared to A549 cells
(Fig. 5A).
When we analyzed the levels of ROS in the co-cultures, we observed
a change of them for H1299 cells, but not for A549 cells, that maintain
the same ROS levels (Fig. 5B-C). Interestingly in H1299 co-culture, ROS
levels increase in both cell types, suggesting some kind of reciprocal
signal.
In addition, as well as for membrane potential, there is a diﬀerential
eﬀect of the co-culture with diﬀerent ﬁbroblast cells for ROS. The co-
culture with the AF produces a greater increase of ROS in the tumor
cells than the co-culture with CF1. On the contrary, the increase of ROS
in both ﬁbroblasts was similar.
The diﬀerences in basal ROS levels between tumor cells might ex-
plain why this metabolic reprogramming is restricted to the H1299
cells, while A549 cells are not capable of producing this eﬀect.
Reinforcing our results, the role of ROS in this phenomenon has been
pointed out previously as the starting mechanism for this process [10].
On the other hand, it has been described how an increase of ROS in
the cell media produces an increase of the ﬁbroblast TGF-β levels [44].
Our results showed an increase of TGF-β mRNA levels for all the cell
lines when co-cultured (Fig. 5D). Again, the eﬀect on the tumor cell line
is greater when it is co-cultured with the AF. In turn TGF-β levels are
key in the metabolic reprogramming towards an increase of ﬁbroblast
glycolysis and production of lactic acid, substrate for the tumor cells
[26,36]. When we incubate the cells with TGF-β we see a similar eﬀect
to that produced by the co-culture; tumor cells increase the MIMP while
ﬁbroblasts reduce it. On the other hand TGF-β induces an increase of
ROS in the two cell lines similar to that induced by the co-culture
(Fig. 5E).
4. Conclusions
This study provides a better understanding of the actual tumor
metabolism as it focuses on functional studies and takes into account
that tumor cells are not isolated but are in constant communication to
other cell types forming a particular microenvironment. Our results
support the existence of the Reverse Warburg Eﬀect in lung cancer.
Interestingly, this process is restrained to some tumor cell lines; it is not
necessarily associated to ﬁbroblast activation; may be modiﬁed by
diﬀerent ﬁbroblasts and implies an alteration of ROS and TGF-β levels.
Out of all the previously stated information, knowing the metabolic
relationships between diﬀerent cell types may provide: improvements
in diagnosis through better interpretation of PET images; identiﬁcation
of diﬀerent groups of patients according to their metabolic micro-
environment that could have diﬀerent prognoses; or even the discovery
of key therapeutic targets for developing new drugs.
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